<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>patients tended significantly to have keratoplasty done at 20-30 years,while female patients at more than 30 years of age.Conclusions: In this hospital-based KC study, the severity is highwith an early onset and more rapid progress to advanced stage at ayounger age. Female patients had more sever disease. These may berelated to genetic and / or environmental factors. The results haveimplications for KC screening in Saudi Arabia (and probably nearbyMiddle-Eastern countries), to improve early detection andmanagment.Commercial Relationships: Samar A. Al-Swailem, None; SamuelC. Yiu, None; Abdullah Al-Assiri, None; Nasira Asghar, None;Albaraa Al-Qassimi, NoneProgram Number: 5301 Poster Board Number: C0220Presentation Time: 2:45 PM - 4:30 PMIncreased expression of secreted frizzled-related protein-1(SFRP-1) and microtubule-associated protein light chain 3 (LC3)in keratoconusOmer Iqbal, George Fisher, Samir Vira, Daniel Kahn, Daneyal Syed,Jawed Fareed, Charles S. Bouchard. Ophthalmology, Loyola,Maywood, IL.Purpose: To study the expression of secreted frizzled-related protein-1 (SFRP-1) and Light Chain 3 (LC3), an autophagy marker, inkeratoconus and to determine the proteomic profile of normal andkeratoconic epithelial and stromal layers by ProteinChip® usingSELDI-TOF-MSMethods: Under an IRB approved protocol, surgically discarded andde-identified normal donor (n=10) and keratoconus corneas (n=10)were obtained. A segment of the cornea was fixed in formalin forimmunohistochemical staining. From the remaining cornea theendothelium-Descemets membrane was removed. The endotheliumfree cornea was soaked in prewarmed 20mM EDTA solution for 30minutes and forceps were used to strip the epithelial and the stromallayers. The samples were homogenized and the proteinconcentrations adjusted to 1mg/ml. The homogenates were analyzedusing SELDI-TOF-MS. The formalin fixed paraffin-embeddedcorneal samples were cut into sections and mounted on slides. SFRP-1 antibody and LC3 antibody were used to performimmunohistochemical staining.Results: The proteomic profile showed absence of peaks in the 20-150 kDa range in the keratoconic epithelium. However, there weredistinct peaks in keratoconus at 10.8, 12.7, 13.1, 14.6, and 15.8 kDawhich were absent in normal samples. High expressivity of SFRP-1and LC3 was observed in the keratoconus corneas. There alsoappeared to be a correlation between the expression of SFRP1 andLC3 in keratoconus tissues. Low expressivity of SFRP1 resulted inlow expressivity of LC3 while medium-high expressivity of SFRP1resulted in medium to high expressivity of LC3.Conclusions: Increased expression of SFRP-1 and LC3 was observedin Keratoconus cornea. Keratocyte autophagy associated withKeratoconus may play a role in the pathogenesis of Keratoconus.Commercial Relationships: Omer Iqbal, None; George Fisher,None; Samir Vira, None; Daniel Kahn, None; Daneyal Syed,None; Jawed Fareed, None; Charles S. Bouchard, NoneSupport: Illinois Society for the Prevention of BlindnessProgram Number: 5302 Poster Board Number: C0221Presentation Time: 2:45 PM - 4:30 PMIL1B promoter polymorphisms are associated with keratoconusin a Japanese populationTakenori Mikami 1, 2 , Akira Meguro 1 , Takeshi Teshigawara 2 , MasakiTakeuchi 1 , Misaki Ishioka 1, 3 , Miki Iwasaki 3 , Kazumi Fukagawa 3 ,Kenji Konomi 4 , Jun Shimazaki 4 , Nobuhisa Mizuki 1 . 1 Ophthalmologyand Visual Science, Yokohama City University Graduate School ofMedicine, Yokohama, Japan; 2 Yokosuka Chuoh Eye Clinic,Yokosuka, Japan; 3 Ryogoku Eye Clinic, Tokyo, Japan; 4 Departmentof Ophthalmology, Ichikawa General Hospital, Tokyo DentalCollege, Ichikawa, Japan.Purpose: Previous study reported that the polymorphisms ofinterleukin 1 alpha (IL1A) and IL1B gene regions were associatedwith keratoconus in a Korean population. In this study, weinvestigated whether the IL1A and IL1B polymorphisms areassociated with keratoconus in a Japanese population.Methods: One hundred and sixty-nine Japanese patients withkeratoconus and 390 Japanese healthy controls were recruited. Wegenotyped one IL1A single-nucleotide polymorphism (SNP)(rs2071376) and two IL1B SNPs (rs1143627 and rs16944), and thefrequencies of alleles, genotypes, and haplotypes were comparedbetween cases and controls.Results: The significant associations were observed for rs1143627 (-31 T>C) and rs16944 (-511 C>T) in the IL1B promoter region, andthe T allele of rs1143627 and the C allele of rs16944 had anincreased risk of keratoconus (P = 0.014, OR = 1.38 and P = 0.033,OR = 1.33, respectively). The TT genotype of rs1143627 wasassociated with an increased risk for keratoconus (P = 0.033, OR =1.52). The CC genotype of rs16944 also showed an increased risk forkeratoconus, but this did not reach statistical significance (P = 0.058,OR = 1.45). For rs2071376 in IL1A, there were no significantdifferences of allele and genotype frequencies between cases andcontrols. With regard to haplotypic diversity, the haplotype createdby the T allele of rs1143627 and the C allele of rs16944 had a 1.72-fold increased risk of keratoconus (P = 4.0 × 10-5).Conclusions: Our results replicate associations reported recently in aKorean population. This suggests that the IL1B gene play animportant role in the development of keratoconus through geneticpolymorphisms.Commercial Relationships: Takenori Mikami, None; AkiraMeguro, None; Takeshi Teshigawara, None; Masaki Takeuchi,None; Misaki Ishioka, None; Miki Iwasaki, None; KazumiFukagawa, None; Kenji Konomi, None; Jun Shimazaki, SantenPharmaceutical Co. (F), Otsuka Pharmaceutical Co. (F), AbottMedical Optics (F); Nobuhisa Mizuki, NoneSupport: None in the SupportProgram Number: 5303 Poster Board Number: C0222Presentation Time: 2:45 PM - 4:30 PMKeratoconus Gene Mapping: Candidate Genes in the 14q11.2homozygous regionGovindasamy Kumaramanickavel 1 , Venkata Ramana Anandula 1 ,Vedam Ramprasad 3 , Nalla Thambi Jeyabalan 1 , Arkasubhra Ghosh 1 ,Rohit Shetty 2 . 1 Basic Science Research, Narayana Nethralaya,Bangalore, India; 2 <strong>Cornea</strong>, Narayana Nethralaya, Bangalore, India;3 Spinco-Biotech, Chennai, India.Purpose: Keratoconus (KC) is the most common corneal dystrophywith a prevalence rate of 0.05% of people in the USA, even though itis classified under rare diseases. Indian subcontinent has a four foldgreater incidence of the disease. The precise etiopathogenesis of KCis unclear. However, strong family history and large autosomaldominant and few recessive pedigrees' linkage with the disorder hasshown that genetics is one of the leading causes for KC. This study isto map the gene that is causative of the disease in a consanguineousautosomal recessive family.Methods: The family members underwent detailed ophthalmicevaluation including corneal topography. The members of theconsanguineous family were bled for DNA with all ethicalconsiderations. The samples were run on genomewide Affymetrix©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>SNP 6.0 GeneChip and the data were analyzed using theHomozygosity Mapper software. Further bioinformatic analyses ofthe chromosomal region identified was done by using genome-widestudy tools on the UCSC genome browser.Results: Homozygosity mapping reveals the causative region in thisfamily on chromosome 14q11.2 and associated with the SNPrs3811259. Genome browser shows the SNP centeromeric to TCRalphagene (TCRA). The region is linked to inflammatory boweldisease (IBD) and also to several transcription factor and histonedeacetylase binding sites such as FOXA1 (estrogen receptor), CTCF(11-zinc finger protein) etc and histone modifier binding sites likeHDAC2, p300 etc. A few keratoconus related candidate genes likeAPEX1 (multifunctional DNA repair enzyme), CIDE-B (cell deathinducingDFFA-like effector b) are in this region.Conclusions: There are the few candidate genes for KC in thehomozygously linked 14q11.2 region. IBD could be indicative of aninflammatory pathway involvement in the KC disease pathogenesis.Furthermore, the presence of prevalence of transcription factorbinding sites as per genome-wide ChIP-seq data and histonemodification marks suggests this region to be transcriptionally active.Interestingly, APEX1, a DNA repair gene and CIDE-B, which has arole in apoptosis, is highly expressed in the KC cornea indicating theinvolvement in non-canonical roles. Thus, this chromosomal regionmay have the key causative role gene for KC etiopathogenesis.Commercial Relationships: Govindasamy Kumaramanickavel,None; Venkata Ramana Anandula, None; Vedam Ramprasad,None; Nalla Thambi Jeyabalan, None; Arkasubhra Ghosh, None;Rohit Shetty, NoneSupport: Narayana Nethralaya FoundationProgram Number: 5304 Poster Board Number: C0223Presentation Time: 2:45 PM - 4:30 PMHomozygosity Mapping of Keratoconus to 12p13.1 region: TheIdeal Candidate GenesVenkata Ramana Anandula 1 , Venkata Ramana Anandula 1 , VedamRamprasad 2 , Nalla Thambi Jeyabalan 1 , Rohit Shetty 1 , ArkasubhraGhosh 1 , Govindasamy Kumaramanickavel 1 . 1 Basic Science Research,Narayana Nethralaya, Bangalore, India; 2 Advanced Genomics,Spinco Biotech, Chennai, India.Purpose: Kertoconus (KC) a non-inflammatory disease results inprogressively thinning of the cornea resulting to a conical shapecausing refractive errors and visual disturbances. Linkage analyses onautosomal dominant and recessive families have identified variousloci (16q22.3-23.1, 20q12, 3p14-q13, 5q14.3-q21.1, 15q 22.33-24.2,17p13, regions on chromosomes 9, 4, 11, 12, 14) for KC, though sofar no gene has been identified. Aim of this study is to map the genefor KC autosomal recessive consanguineous family of Asian Indianorigin.Methods: After ophthalmic evaluation including corneal topographyand blood samples were collected for DNA analysis from aconsanguineous KC family. Gene mapping was done usingAffymetrix SNP 6.0 GeneChip using Homozygosity Mappersoftware. Using genome-wide study tools on the UCSC genomebrowser, we did further bioinformatic analyses of the chromosomalregion identified.Results: Homozygosity data showed the susceptible chromosomeregion 12p13.1 associated with the SNP rs1544671. The region islinked to important disorders such as retinal cone dystrophy andinflammatory bowel disease (IBD). Genome browser analysis showsthe SNP centeromeric to Ras related and estrogen regulated growthinhibitor (RERG) and Ras-related small GTP-binding proteins(ARHGDIB). However, genomewide ChIP-seq and ChIA-Petanalyses demonstrate few transcription factor binding sites in thisarea including CTCF and ER-alpha.Conclusions: The homozygosity linked 12p13.1 region is rich ingenes where the IBD could be suggestive of an inflammatorypathway involvement in the KC disease pathogenesis. IBD andretinal cone dystrophy could be indicative of an alternate pathwayinvolvement in the KC disease pathogenesis. Although this regionshows limited transcriptional activity, the presence of importantgrowth inhibitory genes such as RERG, which has been shown to betumor suppressors, may have important roles in KC pathophysiology.Sequencing the region should identify the causative gene in thisfamily.Commercial Relationships: Venkata Ramana Anandula, None;Venkata Ramana Anandula, None; Vedam Ramprasad, None;Nalla Thambi Jeyabalan, None; Rohit Shetty, None; ArkasubhraGhosh, None; Govindasamy Kumaramanickavel, NoneProgram Number: 5305 Poster Board Number: C0224Presentation Time: 2:45 PM - 4:30 PMUse of the polygenic model to predict risk of keratoconus usingGWAS dataXiaohui Li 1, 2 , Yelena Bykhovskaya 2, 3 , Talin Haritunians 1 , DavidSiscovick 4 , Anthony J. Aldave 5 , Loretta B. Szczotka-Flynn 6 , Sudha K.Iyengar 7 , Jerome I. Rotter 1 , Kent Taylor 1 , Yaron S. Rabinowitz 3 .1 Medical Genetics, Cedars-Sinai Medical Center, Los Angeles, CA;2 <strong>Cornea</strong> Genetic Eye Institute, Cedars-Sinai Medical Center, LosAngeles, CA; 3 Regenerative Medicine Institute, Cedars-SinaiMedical Center, Los Angeles, CA; 4 Cardiovascular Health ResearchUnit, University of Washington, Seattle, WA; 5 The Jules Stein EyeInstitute, University of California Los Angeles, Los Angeles, CA;6 Ophthalmology & Visual Sciences, Case Western ReserveUniversity, Cleveland, OH; 7 Epidemiology & Biostatistics, CaseWestern Reserve University, Cleveland, OH.Purpose: The genetic contribution of individual SNPs to keratoconussusceptibility is usually modest and cannot be identified without largesample sizes. Thus, to begin to estimate the genetic contribution tokeratoconus, we used polygenic modeling to generate genetic scores,utilizing combination of SNPs each with a small genetic effect,estimated from our genome-wide association study (GWAS)discovery cohort and tested in our GWAS replication cohort.Methods: A discovery panel of 222 Caucasian keratoconus patientsand 3324 controls was genotyped using the Illumina 370K beadchip.Selected SNPs identified by GWAS at p
- Page 2 and 3:
ARVO 2013 Annual Meeting Abstracts
- Page 4 and 5:
ARVO 2013 Annual Meeting Abstracts
- Page 6 and 7:
ARVO 2013 Annual Meeting Abstracts
- Page 8 and 9:
ARVO 2013 Annual Meeting Abstracts
- Page 10:
ARVO 2013 Annual Meeting Abstracts
- Page 13 and 14:
ARVO 2013 Annual Meeting Abstracts
- Page 16 and 17:
ARVO 2013 Annual Meeting Abstracts
- Page 18 and 19:
ARVO 2013 Annual Meeting Abstracts
- Page 20 and 21:
ARVO 2013 Annual Meeting Abstracts
- Page 22 and 23:
ARVO 2013 Annual Meeting Abstracts
- Page 24 and 25:
ARVO 2013 Annual Meeting Abstracts
- Page 26 and 27:
ARVO 2013 Annual Meeting Abstracts
- Page 28 and 29:
ARVO 2013 Annual Meeting Abstracts
- Page 30 and 31:
ARVO 2013 Annual Meeting Abstracts
- Page 32 and 33:
ARVO 2013 Annual Meeting Abstracts
- Page 34 and 35:
ARVO 2013 Annual Meeting Abstracts
- Page 36 and 37:
ARVO 2013 Annual Meeting Abstracts
- Page 38 and 39:
ARVO 2013 Annual Meeting Abstracts
- Page 40 and 41:
ARVO 2013 Annual Meeting Abstracts
- Page 42 and 43:
ARVO 2013 Annual Meeting Abstracts
- Page 44 and 45:
ARVO 2013 Annual Meeting Abstracts
- Page 46 and 47:
ARVO 2013 Annual Meeting Abstracts
- Page 48 and 49:
ARVO 2013 Annual Meeting Abstracts
- Page 50 and 51:
ARVO 2013 Annual Meeting Abstracts
- Page 52 and 53:
ARVO 2013 Annual Meeting Abstracts
- Page 54 and 55:
ARVO 2013 Annual Meeting Abstracts
- Page 56 and 57:
ARVO 2013 Annual Meeting Abstracts
- Page 58 and 59:
ARVO 2013 Annual Meeting Abstracts
- Page 60 and 61:
ARVO 2013 Annual Meeting Abstracts
- Page 62 and 63:
ARVO 2013 Annual Meeting Abstracts
- Page 64 and 65:
ARVO 2013 Annual Meeting Abstracts
- Page 66 and 67:
ARVO 2013 Annual Meeting Abstracts
- Page 68 and 69:
ARVO 2013 Annual Meeting Abstracts
- Page 70 and 71:
ARVO 2013 Annual Meeting Abstracts
- Page 72 and 73:
ARVO 2013 Annual Meeting Abstracts
- Page 74 and 75:
ARVO 2013 Annual Meeting Abstracts
- Page 76 and 77:
ARVO 2013 Annual Meeting Abstracts
- Page 78 and 79:
ARVO 2013 Annual Meeting Abstracts
- Page 80 and 81:
ARVO 2013 Annual Meeting Abstracts
- Page 82 and 83:
ARVO 2013 Annual Meeting Abstracts
- Page 84 and 85:
ARVO 2013 Annual Meeting Abstracts
- Page 86 and 87:
ARVO 2013 Annual Meeting Abstracts
- Page 88 and 89:
ARVO 2013 Annual Meeting Abstracts
- Page 90 and 91:
ARVO 2013 Annual Meeting Abstracts
- Page 92 and 93:
ARVO 2013 Annual Meeting Abstracts
- Page 94 and 95:
ARVO 2013 Annual Meeting Abstracts
- Page 96 and 97:
ARVO 2013 Annual Meeting Abstracts
- Page 98 and 99:
ARVO 2013 Annual Meeting Abstracts
- Page 100 and 101:
ARVO 2013 Annual Meeting Abstracts
- Page 102 and 103:
ARVO 2013 Annual Meeting Abstracts
- Page 104 and 105:
ARVO 2013 Annual Meeting Abstracts
- Page 106 and 107:
ARVO 2013 Annual Meeting Abstracts
- Page 108 and 109:
ARVO 2013 Annual Meeting Abstracts
- Page 110 and 111:
ARVO 2013 Annual Meeting Abstracts
- Page 112 and 113:
ARVO 2013 Annual Meeting Abstracts
- Page 114 and 115:
ARVO 2013 Annual Meeting Abstracts
- Page 116 and 117:
ARVO 2013 Annual Meeting Abstracts
- Page 118 and 119:
ARVO 2013 Annual Meeting Abstracts
- Page 120 and 121:
ARVO 2013 Annual Meeting Abstracts
- Page 122 and 123:
ARVO 2013 Annual Meeting Abstracts
- Page 124 and 125:
ARVO 2013 Annual Meeting Abstracts
- Page 126 and 127:
ARVO 2013 Annual Meeting Abstracts
- Page 128 and 129:
ARVO 2013 Annual Meeting Abstracts
- Page 130 and 131:
ARVO 2013 Annual Meeting Abstracts
- Page 132 and 133:
ARVO 2013 Annual Meeting Abstracts
- Page 134 and 135:
ARVO 2013 Annual Meeting Abstracts
- Page 136 and 137:
ARVO 2013 Annual Meeting Abstracts
- Page 138 and 139:
ARVO 2013 Annual Meeting Abstracts
- Page 140 and 141:
ARVO 2013 Annual Meeting Abstracts
- Page 142 and 143:
ARVO 2013 Annual Meeting Abstracts
- Page 144 and 145:
ARVO 2013 Annual Meeting Abstracts
- Page 146 and 147:
ARVO 2013 Annual Meeting Abstracts
- Page 148 and 149:
ARVO 2013 Annual Meeting Abstracts
- Page 150 and 151:
ARVO 2013 Annual Meeting Abstracts
- Page 152 and 153:
ARVO 2013 Annual Meeting Abstracts
- Page 154 and 155:
ARVO 2013 Annual Meeting Abstracts
- Page 156 and 157:
ARVO 2013 Annual Meeting Abstracts
- Page 158 and 159:
ARVO 2013 Annual Meeting Abstracts
- Page 160 and 161:
ARVO 2013 Annual Meeting Abstracts
- Page 162 and 163:
ARVO 2013 Annual Meeting Abstracts
- Page 164 and 165:
ARVO 2013 Annual Meeting Abstracts
- Page 166 and 167:
ARVO 2013 Annual Meeting Abstracts
- Page 168 and 169:
ARVO 2013 Annual Meeting Abstracts
- Page 170 and 171:
ARVO 2013 Annual Meeting Abstracts
- Page 172 and 173:
ARVO 2013 Annual Meeting Abstracts
- Page 174 and 175:
ARVO 2013 Annual Meeting Abstracts
- Page 176 and 177:
ARVO 2013 Annual Meeting Abstracts
- Page 178 and 179:
ARVO 2013 Annual Meeting Abstracts
- Page 180 and 181:
ARVO 2013 Annual Meeting Abstracts
- Page 182 and 183:
ARVO 2013 Annual Meeting Abstracts
- Page 184 and 185:
ARVO 2013 Annual Meeting Abstracts
- Page 186 and 187:
ARVO 2013 Annual Meeting Abstracts
- Page 188 and 189:
ARVO 2013 Annual Meeting Abstracts
- Page 190 and 191:
ARVO 2013 Annual Meeting Abstracts
- Page 192 and 193:
ARVO 2013 Annual Meeting Abstracts
- Page 194 and 195:
ARVO 2013 Annual Meeting Abstracts
- Page 196 and 197:
ARVO 2013 Annual Meeting Abstracts
- Page 198 and 199:
ARVO 2013 Annual Meeting Abstracts
- Page 200 and 201:
ARVO 2013 Annual Meeting Abstracts
- Page 202 and 203:
ARVO 2013 Annual Meeting Abstracts
- Page 204 and 205:
ARVO 2013 Annual Meeting Abstracts
- Page 206 and 207:
ARVO 2013 Annual Meeting Abstracts
- Page 208 and 209:
ARVO 2013 Annual Meeting Abstracts
- Page 210 and 211:
ARVO 2013 Annual Meeting Abstracts
- Page 212 and 213:
ARVO 2013 Annual Meeting Abstracts
- Page 214 and 215:
ARVO 2013 Annual Meeting Abstracts
- Page 216 and 217:
ARVO 2013 Annual Meeting Abstracts
- Page 218 and 219:
ARVO 2013 Annual Meeting Abstracts
- Page 220 and 221:
ARVO 2013 Annual Meeting Abstracts
- Page 222 and 223:
ARVO 2013 Annual Meeting Abstracts
- Page 224 and 225:
ARVO 2013 Annual Meeting Abstracts
- Page 226 and 227:
ARVO 2013 Annual Meeting Abstracts
- Page 228 and 229:
ARVO 2013 Annual Meeting Abstracts
- Page 230 and 231:
ARVO 2013 Annual Meeting Abstracts
- Page 232 and 233:
ARVO 2013 Annual Meeting Abstracts
- Page 234 and 235:
ARVO 2013 Annual Meeting Abstracts
- Page 236 and 237:
ARVO 2013 Annual Meeting Abstracts
- Page 238 and 239:
ARVO 2013 Annual Meeting Abstracts
- Page 240 and 241:
ARVO 2013 Annual Meeting Abstracts
- Page 242 and 243:
ARVO 2013 Annual Meeting Abstracts
- Page 244 and 245:
ARVO 2013 Annual Meeting Abstracts
- Page 246 and 247:
ARVO 2013 Annual Meeting Abstracts
- Page 248 and 249:
ARVO 2013 Annual Meeting Abstracts
- Page 250 and 251:
ARVO 2013 Annual Meeting Abstracts
- Page 252 and 253:
ARVO 2013 Annual Meeting Abstracts
- Page 254 and 255:
ARVO 2013 Annual Meeting Abstracts
- Page 256 and 257:
ARVO 2013 Annual Meeting Abstracts
- Page 258 and 259:
ARVO 2013 Annual Meeting Abstracts
- Page 260 and 261:
ARVO 2013 Annual Meeting Abstracts
- Page 262 and 263:
ARVO 2013 Annual Meeting Abstracts
- Page 264 and 265:
ARVO 2013 Annual Meeting Abstracts
- Page 266 and 267:
ARVO 2013 Annual Meeting Abstracts
- Page 268 and 269:
ARVO 2013 Annual Meeting Abstracts
- Page 270 and 271:
ARVO 2013 Annual Meeting Abstracts
- Page 272 and 273:
ARVO 2013 Annual Meeting Abstracts
- Page 274 and 275:
ARVO 2013 Annual Meeting Abstracts
- Page 276 and 277: ARVO 2013 Annual Meeting Abstracts
- Page 278 and 279: ARVO 2013 Annual Meeting Abstracts
- Page 280 and 281: ARVO 2013 Annual Meeting Abstracts
- Page 282 and 283: ARVO 2013 Annual Meeting Abstracts
- Page 284 and 285: ARVO 2013 Annual Meeting Abstracts
- Page 286 and 287: ARVO 2013 Annual Meeting Abstracts
- Page 288 and 289: ARVO 2013 Annual Meeting Abstracts
- Page 290 and 291: ARVO 2013 Annual Meeting Abstracts
- Page 292 and 293: ARVO 2013 Annual Meeting Abstracts
- Page 294 and 295: ARVO 2013 Annual Meeting Abstracts
- Page 296 and 297: ARVO 2013 Annual Meeting Abstracts
- Page 298 and 299: ARVO 2013 Annual Meeting Abstracts
- Page 300 and 301: ARVO 2013 Annual Meeting Abstracts
- Page 302 and 303: ARVO 2013 Annual Meeting Abstracts
- Page 304 and 305: ARVO 2013 Annual Meeting Abstracts
- Page 306 and 307: ARVO 2013 Annual Meeting Abstracts
- Page 308 and 309: ARVO 2013 Annual Meeting Abstracts
- Page 310 and 311: ARVO 2013 Annual Meeting Abstracts
- Page 312 and 313: ARVO 2013 Annual Meeting Abstracts
- Page 314 and 315: ARVO 2013 Annual Meeting Abstracts
- Page 316 and 317: ARVO 2013 Annual Meeting Abstracts
- Page 318 and 319: ARVO 2013 Annual Meeting Abstracts
- Page 320 and 321: ARVO 2013 Annual Meeting Abstracts
- Page 322 and 323: ARVO 2013 Annual Meeting Abstracts
- Page 324 and 325: ARVO 2013 Annual Meeting Abstracts
- Page 328 and 329: ARVO 2013 Annual Meeting Abstracts
- Page 330 and 331: ARVO 2013 Annual Meeting Abstracts
- Page 332 and 333: ARVO 2013 Annual Meeting Abstracts
- Page 334 and 335: ARVO 2013 Annual Meeting Abstracts
- Page 336 and 337: ARVO 2013 Annual Meeting Abstracts
- Page 338 and 339: ARVO 2013 Annual Meeting Abstracts
- Page 340 and 341: ARVO 2013 Annual Meeting Abstracts
- Page 342 and 343: ARVO 2013 Annual Meeting Abstracts
- Page 344 and 345: ARVO 2013 Annual Meeting Abstracts
- Page 346 and 347: ARVO 2013 Annual Meeting Abstracts
- Page 348 and 349: ARVO 2013 Annual Meeting Abstracts
- Page 350 and 351: ARVO 2013 Annual Meeting Abstracts
- Page 352 and 353: ARVO 2013 Annual Meeting Abstracts
- Page 354 and 355: ARVO 2013 Annual Meeting Abstracts
- Page 356 and 357: ARVO 2013 Annual Meeting Abstracts
- Page 358 and 359: ARVO 2013 Annual Meeting Abstracts
- Page 360 and 361: ARVO 2013 Annual Meeting Abstracts
- Page 362 and 363: ARVO 2013 Annual Meeting Abstracts
- Page 364 and 365: ARVO 2013 Annual Meeting Abstracts
- Page 366 and 367: ARVO 2013 Annual Meeting Abstracts
- Page 368 and 369: ARVO 2013 Annual Meeting Abstracts
- Page 370 and 371: ARVO 2013 Annual Meeting Abstracts
- Page 372 and 373: ARVO 2013 Annual Meeting Abstracts
- Page 374 and 375: ARVO 2013 Annual Meeting Abstracts
- Page 376 and 377:
ARVO 2013 Annual Meeting Abstracts
- Page 378 and 379:
ARVO 2013 Annual Meeting Abstracts
- Page 380 and 381:
ARVO 2013 Annual Meeting Abstracts
- Page 382 and 383:
ARVO 2013 Annual Meeting Abstracts